Treating Muscular Dystrophy with CRISPR Gene Editing
Type
Blog Post
..., an individual experiences progressive muscle wasting leading to death at around 30 years of age. Despite...the amount of research conducted on DMD, there is still no good treatment.
The dystrophin gene is very large...approach. Since shorter forms of dystrophin can still be functional, exon skipping is a good option for...non-homologous end joining (NHEJ) pathway. It’s estimated that very little dystrophin correction (about ...could make a huge difference in DMD, and it’s estimated that exon skipping therapies would be applicable...experiment, they found the exon-skipped transcript constituted 59% of total dystrophin mRNA, similar to the ...CRISPR therapy closer to the clinic, much work is still needed. First, CRISPR delivery must be optimized...